Navidea Biopharmaceuticals

-$0.0001 (-0.01%) As of 2:14 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NAVB and other ETFs, options, and stocks.

About NAVB

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate.

CEO
Jed Andrew Latkin, MBA
Employees
11
Headquarters
Dublin, Ohio
Founded
1983

NAVB Key Statistics

Market cap
20.64M
Price-Earnings ratio
—
Dividend yield
—
Average volume
43.85K
High today
$0.6799
Low today
$0.6799
Open price
$0.6799
Volume
424.00
52 Week high
$1.96
52 Week low
$0.5606

NAVB Earnings

-$0.12
-$0.08
-$0.04
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure